- Home
- ACIU vs TCX Comparison
ACIU vs TCX Comparison
Compare ACIU & TCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- TCX
- Stock Information
- Founded
- ACIU 2003
- TCX 1992
- Country
- ACIU Switzerland
- TCX Canada
- Employees
- ACIU N/A
- TCX N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- TCX EDP Services
- Sector
- ACIU Health Care
- TCX Technology
- Exchange
- ACIU Nasdaq
- TCX Nasdaq
- Market Cap
- ACIU 189.1M
- TCX 220.5M
- IPO Year
- ACIU 2016
- TCX 1996
- Fundamental
- Price
- ACIU $2.07
- TCX $21.61
- Analyst Decision
- ACIU Strong Buy
- TCX
- Analyst Count
- ACIU 1
- TCX 0
- Target Price
- ACIU $12.00
- TCX N/A
- AVG Volume (30 Days)
- ACIU 125.1K
- TCX 43.8K
- Earning Date
- ACIU 08-05-2025
- TCX 08-07-2025
- Dividend Yield
- ACIU N/A
- TCX N/A
- EPS Growth
- ACIU N/A
- TCX N/A
- EPS
- ACIU N/A
- TCX N/A
- Revenue
- ACIU $32,014,254.00
- TCX $369,427,000.00
- Revenue This Year
- ACIU N/A
- TCX N/A
- Revenue Next Year
- ACIU $533.21
- TCX N/A
- P/E Ratio
- ACIU N/A
- TCX N/A
- Revenue Growth
- ACIU 91.20
- TCX 6.66
- 52 Week Low
- ACIU $1.43
- TCX $13.27
- 52 Week High
- ACIU $4.26
- TCX $26.48
- Technical
- Relative Strength Index (RSI)
- ACIU 55.57
- TCX 59.52
- Support Level
- ACIU $2.00
- TCX $21.18
- Resistance Level
- ACIU $2.15
- TCX $22.69
- Average True Range (ATR)
- ACIU 0.13
- TCX 0.77
- MACD
- ACIU -0.01
- TCX 0.06
- Stochastic Oscillator
- ACIU 80.92
- TCX 59.54
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About TCX Tucows Inc.
Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains. Geographically company operates in USA, Canada and Europe.